MDA 19 (Standard)
MDA 19 (Standard) is the analytical standard of MDA 19. This product is intended for research and analytical applications. MDA 19 is a potent and selective agonist of human cannabinoid receptor 2 (CB2), with a Ki of 43.3 nM. MDA 19 has antiallodynic effects in a rat model of neuropathic pain and does not affect rat locomotor activity.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 98%
- CAS No.: 1048973-47-2
- 화학식: C21H23N3O2
- 분자량:349.43
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- 순도&문서
-
Help & FAQs
-
HY-15443
AM251CB1 Receptor Antagonist -
HY-15451
MDA 19CB2 Agonist -
HY-13439
SR144528CB2 Receptor Antagonist -
HY-10013
TaranabantCB1 Receptor Invert Agonist -
HY-18697
JD-5037CB1 Receptor Antagonist -
HY-10871
OtenabantCannabinoid Receptor Antagonist -
HY-14167
GW842166XCannabinoid Receptor Agonist -
HY-13288
Org 27569Cannabinoid Receptor Modulator -
HY-14791A
(±)-IbipinabantCannabinoid Receptor Antagonist -
HY-15420
BML-190Cannabinoid Receptor Agonist -
HY-16642A
LY2828360 -
HY-100488
Bay 59-3074CB1/CB2 Receptor Agonist
Product Information
Information
신청
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 1048973-47-2
-
분자량 349.43
-
화학식 C21H23N3O2
-
SMILES
O=C(C1=CC=CC=C1)N/N=C2C(N(C3=C\2C=CC=C3)CCCCCC)=O
-
Synonyms
BZO-HEXOXIZID (Standard)
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
[1]. Diaz, Philippe; Xu, Jijun; Astruc-Diaz, Fanny et al. Design and Synthesis of a Novel Series of N-Alkyl Isatin Acylhydrazone Derivatives that Act as Selective Cannabinoid Receptor 2 Agonists for the Treatment of Neuropathic Pain. Journal of Medicinal Chemistry (2008), 51(16), 4932-4947. [Content Brief]
[2]. Xu JJ, Diaz P, Astruc-Diaz F et al. Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain. Anesth Analg. 2010 Jul;111(1):99-109. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
MDA 19 (Standard) Related Classifications
HY-15451R Related Classifications
Powered by Bioz